DALLAS, March 24, 2015 /PRNewswire/ --
According to a new market research report " Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein type (Monoclonal antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) -Global Forecast to 2020", published by MarketsandMarkets, The Global Protein Engineering Market is expected to reach around $1,463.0 Million by 2020 with a CAGR of 15.7% during the forecast period (2015 to 2020).
Browse 100 market data Tables and 53 Figures spread through 180Pages and in-depth TOC on "Protein Engineering Market"
Early buyers will receive 10% customization on this report.
The Global Protein Engineering Market is poised to reach $1,463.0 million by 2020 from $610.3 million in 2014, at a CAGR of 15.7% from 2015 to 2020.
Factors such as increase in adoption of protein drugs over non-protein drugs, high prevalence rate of lifestyle diseases, growth in funding for protein engineering, and reduction in overall timeline and cost for drug discovery are the major drivers of the Protein Engineering Market. However, expensive and high maintenance tools and instruments used in protein engineering and dearth of trained personnel are hindering the market.
Inquiry before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=898
The Protein Engineering Market is segmented on the basis of product, technology, protein type, end user, and region. By product, the protein engineering market is categorized into instruments, reagents, and services and software. The instruments segment accounted for the largest share-41.4%-of the global protein engineering market in 2014.
The Protein Engineering Technology Market is categorized into rational protein design, and irrational protein design. In this market, rational protein design is the largest and fastest growing segment. On the basis of end user the protein engineering market is classified into academic research institutes, pharmaceutical and biotechnology companies, and contract research organizations. In this market, pharmaceutical and biotechnology companies segment holds the major share followed by contract research organizations.
Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies are the largest as well as fastest growing segment of the protein engineering protein type market. This growth is attributed to the increase in adoption of them for various therapies such as cancer and autoimmune diseases.
On the basis of geography, the Protein Engineering Market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is further segmented into U.S. and Canada. Asia is further segmented into China, Japan, India and Rest of Asia. In 2014, North America accounted for the largest share of the protein engineering market, followed by Europe. Both markets are estimated to register double-digit growth rates over the next five years.
Key players operating in the Protein Engineering Market are Agilent Technologies (U.S.), AB-Sciex (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).
Browse Related Reports:
Protein Characterization and Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectroscopy), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery & Development), & by End Users - Global Forecast to 2019
Protein Expression Market by Products (Expression Vector, Service, Reagent), Application (Industrial, Therapeutic), Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast) & by End User (Pharmaceutical, Biotechnology, CRO) - Global Forecast to 2018
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets